Alan Venook

Alan Venook

UNVERIFIED PROFILE

Are you Alan Venook?   Register this Author

Register author
Alan Venook

Alan Venook

Publications by authors named "Alan Venook"

Are you Alan Venook?   Register this Author

100Publications

5189Reads

8Profile Views

Reply to S. Sorscher.

J Clin Oncol 2019 Sep 3;37(25):2291-2293. Epub 2019 Jul 3.

Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01366DOI Listing
September 2019

Vitamin D Levels in Patients with Colorectal Cancer and Matched Household Members.

J Clin Nutr Food Sci 2019 12;2. Epub 2019 Jul 12.

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697376PMC
July 2019

Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers.

PLoS One 2018 23;13(7):e0199423. Epub 2018 Jul 23.

Department of Medicine and Helen Diller Family Comprehensive Cancer Center (HFCCC), University of California, San Francisco (UCSF), San Francisco, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199423PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056029PMC
January 2019

Of Microbes and Microsatellites.

Cancer Immunol Res 2018 11;6(11):1290-1291

Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-18-0567DOI Listing
November 2018

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.

N Engl J Med 2018 Jul;379(1):54-63

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (G.K.A.-A.); Royal Free Hospital and University College London, London (T.M.); National Taiwan University Hospital, Taipei (A.-L.C.), and the Department of Medical Oncology, Liouying Chi Mei Hospital, Tainan (Y.C.) - both in Taiwan; USC Norris Comprehensive Cancer Center, Los Angeles (A.B.E.-K.), UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco (A.P.V., R.K.K.), and Exelixis, Alameda (C.H., A.E.B.-H., G.S.) - all in California; Humanitas Cancer Center, Humanitas Clinical and Research Center, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano (L.R., T.P.), the Department of Medical and Surgical Sciences, University of Bologna, Bologna (L.B.), and Medical Oncology Unit 1, Istituto Oncologico Veneto, IRCCS, Padua (V.Z.) - all in Italy; Asan Medical Center, University of Ulsan College of Medicine, Seoul (B.-Y.R., M.-H.R.), and the National Cancer Center, Goyang (J.-W.P.) - both in South Korea; Trakya University School of Medicine, Edirne, Turkey (I.C.); Groupement Hospitalier Nord, Lyon (P.M.), and Hôpital Haut-Lévêque, Centre Hospitalier Universitaire Bordeaux, Bordeaux (J.-F.B.) - both in France; the Department of Medical Oncology, Academic Medical Center, Amsterdam (H.-J.K.); and the Chinese University of Hong Kong, State Key Laboratory in Oncology in South China, Hong Kong (S.L.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1717002DOI Listing
July 2018

Advances in Adjuvant Therapy for Colon Cancer: P value or Practical Value.

Authors:
Alan P Venook

J Clin Oncol 2018 05 5;36(15):1461-1462. Epub 2018 Apr 5.

Alan P. Venook, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.8423DOI Listing
May 2018

Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancer.

J Natl Compr Canc Netw 2018 05;16(5S):611-615

Presented by Axel Grothey, MD, Mayo Clinic Cancer Center, Phoenix, Arizona, and Alan P. Venook, MD, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://www.jnccn.org/lookup/doi/10.6004/jnccn.2018.0038
Publisher Site
http://dx.doi.org/10.6004/jnccn.2018.0038DOI Listing
May 2018

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

J Clin Oncol 2018 04 28;36(11):1112-1120. Epub 2018 Feb 28.

Temidayo Fadelu, Sui Zhang, Robert J. Mayer, Shuji Ogino, Kimmie Ng, Jeffrey Meyerhardt, and Charles S. Fuchs, Dana-Farber/Partners CancerCare; Shuji Ogino, Kana Wu, Walter Willett, and Edward Giovannucci, Harvard TH Chan School of Public Health; Shuji Ogino, Edward Giovannucci, and Ying Bao, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University, Durham; Michael Messino, Southeast Clinical Oncology Research Consortium, Mission Hospitals, Asheville, NC; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Rex B. Mowat, Toledo Community Hospital Oncology Program, Toledo, OH; Renaud Whittom, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada; Alexander Hantel, Loyola University Stritch School of Medicine, Naperville; Al B. Benson, Robert H Lurie Comprehensive Cancer Center, Northwestern University; Hedy L. Kindler, University of Chicago Comprehensive Cancer, Chicago, IL; Daniel M. Atienza, Virginia Oncology Associates, Norfolk, VA; Alan Venook, University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA; and Charles S. Fuchs, Yale Cancer Center, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891130PMC
April 2018

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

J Clin Oncol 2017 Nov 4;35(32):3671-3677. Epub 2017 Oct 4.

Charles S. Fuchs, Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT; Charles S. Fuchs, Peter C. Enzinger, Jeffrey Meyerhardt, and Robert J. Mayer, Dana-Farber/Partners CancerCare; Harvey J. Mamon and Richard S. Swanson, Brigham and Women's Hospital, Boston, MA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University; Christopher G. Willett, Duke Cancer Institute, Duke University Medical Center, Durham; Joel E. Tepper, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC; Daniel G. Haller, University of Pennsylvania, Philadelphia, PA; Tomislav Dragovich, Banner MD Anderson Cancer Center, Gilbert; Leonard L. Gunderson, Mayo Clinic, Scottsdale, AZ; Steven R. Alberts, Mayo Clinic, Rochester, MN; Georg A. Bjarnason, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Richard M. Goldberg and Kristen Ciombor, Ohio State University, James Cancer Hospital, Columbus, OH; Alan P. Venook, University of California at San Francisco, San Francisco, CA; David Ilson and Eileen O'Reilly, Memorial Sloan Kettering Cancer Center, New York, NY; and David J. Berg, University of Iowa/Holden Comprehensive Cancer Center, Iowa City, IA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.2130
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.2130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678342PMC
November 2017

Reply to L. Casadaban et al.

J Clin Oncol 2017 04 23;35(12):1373-1374. Epub 2017 Jan 23.

Donna Niedzwiecki, Duke University, Durham, NC; Wendy L. Frankel, The Ohio State University, Columbus, OH; Alan P. Venook, University of California, San Francisco, San Francisco, CA; Xing Ye, Duke University, Durham, NC; Paula N. Friedman, Northwestern University, Chicago, IL; Richard M. Goldberg, The Ohio State University, Columbus, OH; Robert J. Mayer, Dana-Farber Cancer Institute, Boston, MA; Thomas A. Colacchio, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Jude Marie Mulligan, Timothy S. Davison, Eamonn O'Brien, and Peter Kerr, Almac Diagnostics, Craigavon, United Kingdom; Patrick G. Johnston, Queen's University, Belfast, United Kingdom; Richard D. Kennedy and D. Paul Harkin, Almac Diagnostics, Craigavon, United Kingdom; Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Monica M. Bertagnolli, Brigham and Women's Hospital, Boston, MA; Robert S. Warren, University of California, San Francisco, San Francisco, CA; and Federico Innocenti, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.2646
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.2646DOI Listing
April 2017

Adjuvant Therapy Trials.

Cancer J 2016 May-Jun;22(3):196-8

From the Gastrointestinal Oncology, University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000188DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349297PMC
January 2017

Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal Cancer.

J Natl Compr Canc Netw 2017 01;15(1):3-8

From University of California San Francisco, Hellen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564419PMC
http://dx.doi.org/10.6004/jnccn.2017.0002DOI Listing
January 2017

Right-sided vs left-sided colorectal cancer.

Authors:
Alan P Venook

Clin Adv Hematol Oncol 2017 Jan;15(1):22-24

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.

View Article

Download full-text PDF

Source
January 2017

Role of Biologics in Colon Cancer: Still Not Clear.

J Oncol Pract 2016 12;12(12):1229-1230

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.018697DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455590PMC
December 2016

Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.

J Natl Compr Canc Netw 2016 12;14(12):1536-1543

From the Department of Medicine and Helen Diller Family Comprehensive Cancer Center; Department of Radiology and Biomedical Imaging; and Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551390PMC
http://dx.doi.org/10.6004/jnccn.2016.0165DOI Listing
December 2016

Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials.

Pancreas 2016 11;45(10):1394-1400

From the *Department of Medicine, Stanford University School of Medicine, Stanford, CA; †Department of Public Health Sciences, University of Miami School of Medicine, Miami, FL; ‡Department of Oncology, Kaiser Permanente Medical Center, Vallejo; §Department of Oncology, Kaiser Permanente Medical Center, Santa Clara; Departments of ∥Medicine, and ¶Biostatistics and Computational Biology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000659DOI Listing
November 2016

Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).

J Clin Oncol 2016 09 18;34(25):3047-53. Epub 2016 Jul 18.

Donna Niedzwiecki and Xing Ye, Duke University, Durham; Federico Innocenti, University of North Carolina at Chapel Hill, Chapel Hill, NC; Wendy L. Frankel and Richard M. Goldberg, The Ohio State University, Columbus, OH; Alan P. Venook and Robert S. Warren, University of California-San Francisco, San Francisco, CA; Paula N. Friedman, The University of Chicago, Chicago, IL; Robert J. Mayer, Dana-Farber Cancer Institute; Monica M. Bertagnolli, Brigham and Women's Hospital, Boston, MA; Thomas Anthony Colacchio, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Jude Marie Mulligan, Timothy S. Davison, Eamonn O'Brien, Peter Kerr, Richard D. Kennedy, and D. Paul Harkin, Almac Diagnostics, Craigavon; Patrick G. Johnston, Queen's University, Belfast, Northern Ireland; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.4699DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012711PMC
September 2016

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers.

J Clin Oncol 2016 08 5;34(23):2736-42. Epub 2016 Jul 5.

Peter C. Enzinger and Robert J. Mayer, Dana-Farber Cancer Institute, Harvard Medical School, and Alliance for Clinical Trials in Oncology, Boston, MA; Barbara Ann Burtness and Steven J. Cohen, Fox Chase Cancer Center; Barbara Ann Burtness, Steven J. Cohen, and Al Bowen Benson III, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group, Philadelphia, PA; Donna Niedzwiecki, Xing Ye, and Kathe Douglas, Alliance Statistics and Data Center, Duke University, Durham, NC; David H. Ilson, Memorial Sloan Kettering Cancer Center and Alliance for Clinical Trials in Oncology, New York, NY; Victoria Meucci Villaflor, University of Chicago Medicine and Alliance for Clinical Trials in Oncology; Al Bowen Benson III, Northwestern University Feinberg School of Medicine, Chicago, IL; Alan Venook, University of California San Francisco Helen Diller Family Comprehensive Cancer Center and Alliance for Clinical Trials in Oncology, San Francisco, CA; and Richard M. Goldberg, Ohio State University James Comprehensive Cancer Center and Alliance for Clinical Trials in Oncology, Columbus, OH.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/06/30/JCO.2015.65
Web Search
http://dx.doi.org/10.1200/JCO.2015.65.5092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019745PMC
August 2016

Gene Expression Profiling of Evening Fatigue in Women Undergoing Chemotherapy for Breast Cancer.

Biol Res Nurs 2016 07 8;18(4):370-85. Epub 2016 Mar 8.

School of Nursing, University of California, San Francisco, CA, USA Institute for Human Genetics, University of California, San Francisco, CA, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1099800416629209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575784PMC
July 2016

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.

Radiology 2016 May 8;279(2):630-40. Epub 2016 Jan 8.

From Vascular and Interventional Radiology, Johns Hopkins University School of Medicine, 600 N Wolfe St, Blalock 545, Baltimore, MD 21287 (J.F.G.); Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan (M.K.); Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Tex (J.A.M.); University of California-San Francisco, San Francisco, Calif (A.P.V.); Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (X.P.C.); Department of Gastroenterology and Hepatology, INSERM U954, University Hospital, University of Lorraine, Nancy, France (J.P.B.); Policlínica Metropolitana, Caracas, Venezuela (L.D.); Kyorin University School of Medicine, Mitaka, Tokyo, Japan (J.F.); Hospital Angeles Clínica Londres, Mexico City, Mexico (L.L.d.G.); University Hospital of Larissa, Larissa, Greece (C.P.); Virginia Commonwealth University Medical Center, Richmond, Va (A.J.S.); Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan (T.T.); Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China (S.L.Y.); The Catholic University of Korea, Seoul, Korea (S.K.Y.); Global Medical Affairs, Bayer Healthcare Pharmaceuticals, Whippany, NJ (K.N.); Clinical Statistics, Bayer Healthcare Pharmaceuticals, Whippany, NJ (R.L.); Global Medical Affairs and Pharmacovigilance, Bayer Pharma AG, Berlin, Germany (S.H.); and Division of Diagnostic Imaging and Intervention, Pisa University Hospital and School of Medicine, Pisa, Italy (R.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2015150667DOI Listing
May 2016

Metastatic Colorectal Cancer: Lessons Learned, Future Possibilities.

Authors:
Alan P Venook

J Natl Compr Canc Netw 2016 05;14(5 Suppl):666-8

Presented by Alan P. Venook, MD, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0187DOI Listing
May 2016

A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.

Pancreas 2016 Mar;45(3):370-5

From the *Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA; †Division of Hematology/Oncology, University of Wisconsin, Madison, WI; ‡Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; and §Department of Radiology and ∥Division of Hematology/Oncology, University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908466PMC
March 2016

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer.

J Clin Oncol 2015 Dec 21;33(34):4023-31. Epub 2015 Sep 21.

Ryan B. Corcoran, Eunice L. Kwak, and David P. Ryan, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA; Chloe E. Atreya, Adil Daud, and Alan P. Venook, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles, CA; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver; Wells A. Messersmith, University of Colorado Cancer Center and University of Colorado, Aurora, CO; Johanna C. Bendell, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Razelle Kurzrock and Scott Kopetz, University of Texas, MD Anderson Cancer Center, Houston, TX; Mariaelena Pierobon, Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA; Peng Sun, Elizabeth Cunningham, Shonda Little, Keith Orford, Monica Motwani, and Yuchen Bai, GlaxoSmithKline, Philadelphia, PA; and Kiran Patel, Incyte, Wilmington, DE.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/34/4023.full.pdf
Web Search
http://jco.ascopubs.org/content/suppl/2015/09/21/JCO.2015.63
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.2471
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.63.2471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669588PMC
December 2015

Colorectal cancer: all hands on deck.

Am Soc Clin Oncol Educ Book 2014 :83-9

From the Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, San Francisco, CA; Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY; UNC/Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.83DOI Listing
November 2015

Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

J Clin Oncol 2015 Nov 17;33(31):3598-607. Epub 2015 Aug 17.

Brendan J. Guercio, Shuji Ogino, and Edward L. Giovannucci, Harvard Medical School; Kaori Sato, Robert J. Mayer, Shuji Ogino, Jeffrey A. Meyerhardt, and Charles S. Fuchs, Dana-Farber Cancer Institute; Frank B. Hu, Shuji Ogino, Kana Wu, Walter C. Willett, and Edward L. Giovannucci, Harvard T.H. Chan School of Public Health; Shuji Ogino and Edward L. Giovannucci, Brigham and Women's Hospital, Boston, MA; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Rex B. Mowat, Toledo Community Hospital Oncology Program, Toledo, OH; Renaud Whittom, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada; Alexander Hantel, Loyola University Stritch School of Medicine, Naperville; Al Benson, Northwestern University; Hedy Kindler, University of Chicago, Chicago, IL; Daniel Atienza, Virginia Oncology Associates, Norfolk, VA; Donna Niedzwiecki and Xing Ye, Duke University Medical Center, Durham; Michael Messino, Southeast Cancer Control Consortium, Mission Hospitals, Asheville, NC; and Alan Venook, University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.5062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622099PMC
November 2015

Trying to Understand Differing Results of FIRE-3 and 80405: Does the First Treatment Matter More Than Others?

J Clin Oncol 2015 Nov 31;33(32):3686-8. Epub 2015 Aug 31.

University of California, San Francisco, San Francisco, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.8495DOI Listing
November 2015

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys.

J Natl Compr Canc Netw 2015 Nov;13(11):1337-46

From UC San Diego Moores Cancer Center, San Diego, California; Stanford Cancer Institute, Stanford, California; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, Ohio; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Washington University, St. Louis, Missouri; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; City of Hope Comprehensive Cancer Center, Los Angeles, California; The West Clinic, Memphis, Tennessee; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; Johns Hopkins University School of Medicine, Baltimore, Maryland; and Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0163DOI Listing
November 2015

The value and effectiveness of angiogenesis inhibitors for colorectal cancer.

Authors:
Alan P Venook

Clin Adv Hematol Oncol 2015 Sep;13(9):561-3

School of Medicine, University of California, San Francisco.

View Article

Download full-text PDF

Source
September 2015

On the Verge: Immunotherapy for Colorectal Carcinoma.

J Natl Compr Canc Netw 2015 Aug;13(8):970-8

From the Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0117DOI Listing
August 2015

Special Series: Advances in GI Cancer.

J Clin Oncol 2015 Jun 27;33(16):1717-20. Epub 2015 Apr 27.

University of California, San Francisco Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.60.8661DOI Listing
June 2015

Rectal Cancer, Version 2.2015.

J Natl Compr Canc Netw 2015 Jun;13(6):719-28; quiz 728

Robert H. Lurie Comprehensive Cancer Center of Northwestern University; UCSF Helen Diller Family Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Vanderbilt-Ingram Cancer Center; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Fred & Pamela Buffett Cancer Center; Mayo Clinic Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Alabama at Birmingham Comprehensive Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Memorial Sloan Kettering Cancer Center; Huntsman Cancer Institute at the University of Utah; Moffitt Cancer Center; University of Michigan Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Duke Cancer Institute; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0087DOI Listing
June 2015

Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.

Int J Cancer 2015 Apr 29;136(8):1967-75. Epub 2014 Sep 29.

Division of Medical Oncology, University of Colorado Denver and University of Colorado Cancer Center, Aurora, CO; Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29225DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323738PMC
April 2015

Bone metastases and skeletal-related events from neuroendocrine tumors.

Endocr Connect 2015 Mar 27;4(1):9-17. Epub 2014 Nov 27.

The UCSF Helen Diller Family Comprehensive Cancer CenterUniversity of California, San Francisco, 1600 Divisadero Street, UCSF Box 1770, San Francisco, California 94143, USAThe Ohio State University Comprehensive Cancer CenterColumbus, Ohio 43210, USANational Comprehensive Cancer NetworkFort Washington, Pennsylvania 19034, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EC-14-0119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285767PMC
March 2015

Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.

J Clin Oncol 2015 Mar 20;33(9):1060-6. Epub 2015 Jan 20.

Adil I. Daud, Michelle T. Ashworth, Alan P. Venook, Jennifer A. Grabowsky, and Pamela N. Munster, University of California, San Francisco, San Francisco; Jonathan W. Goldman and Lee S. Rosen, University of California, Los Angeles, Santa Monica, CA; Jonathan Strosberg and Gregory Springett, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David Mendelson, Pinnacle Oncology Hematology, Scottsdale, AZ; and Sabine Loechner, Frances Shanahan, David Parry, Stuart Shumway, Tomoko Freshwater, Christopher Sorge, Soonmo Peter Kang, and Randi Isaacs, Merck, Whitehouse Station, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.5027DOI Listing
March 2015

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.

J Clin Oncol 2015 Mar 20;33(7):786-809. Epub 2015 Jan 20.

Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/01/16/JCO.2014.59
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.9746
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.9746DOI Listing
March 2015

Bevacizumab vs EGFR antibodies in metastatic colorectal cancer.

Authors:
Alan P Venook

Clin Adv Hematol Oncol 2015 Feb;13(2):90-2

University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
February 2015

Progression-free survival: helpful biomarker or clinically meaningless end point?

J Clin Oncol 2015 Jan 3;33(1):4-6. Epub 2014 Nov 3.

Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.9557DOI Listing
January 2015

Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).

J Natl Cancer Inst 2015 Jan 27;107(1):336. Epub 2014 Nov 27.

Massachusetts General Hospital Cancer Center, Boston, MA (EL); Departments of Medicine, and Health Care Policy, Harvard Medical School, Boston, MA (EL, YH, AM); American Society of Clinical Oncology, Alexandria, VA (RLS); Department of Medicine, University of North Carolina, Chapel Hill, NC (HM); Department of Medicine, Duke University, Durham, NC (HJC); City of Hope, Duarte, CA (AH); Department of Medicine, University of Chicago, Chicago, IL (HLK); Department of Medicine, University of California San Francisco, San Francisco, CA (AV); Yale Cancer Center, New Haven, CT (RL); Department of Medicine, the University of Tennessee, Memphis, TN (HN); Department of Medicine, Ohio State University, Columbus, OH (RMG); Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (SJ).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju336DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271075PMC
January 2015

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

J Natl Cancer Inst 2015 Jan 27;107(1):345. Epub 2014 Nov 27.

: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (KN, JAM, KS, JAC, RJM, SO, CSF); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (ATC, ELG, CSF); Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC (DN); Memorial Sloan-Kettering Cancer Center, New York, NY (LBS); Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL (ABB); Toledo Community Hospital Oncology Program, Toledo, OH (PLS); Hopital du Sacre-Coeur de Montreal, Universite de Montreal, Quebec, Canada (RW); Edward Cancer Center, Naperville, IL (AH); Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG); Division of Medical Oncology, University of California at San Francisco, San Francisco, CA (APV); Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (SO); Department of Epidemiology (SO, ELG) and Department of Nutrition (ELG), Harvard School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271076PMC
January 2015

A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma.

Anticancer Res 2014 Dec;34(12):7357-60

Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, U.S.A.

View Article

Download full-text PDF

Source
December 2014

25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).

J Natl Cancer Inst 2014 Aug 6;106(8). Epub 2014 Aug 6.

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA (KVL, APV); Department of Biostatistics and Bioinformatics, Duke University, Durham, NC (KO, DN); Alliance Statistics and Data Center, Duke University, Durham, NC (KO, CJ, DN); The University of Chicago Medical Center, Chicago, IL (HLK); Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL (MFM); Memorial Sloan-Kettering Cancer Center, New York, NY (EMO); Dana-Farber Cancer Institute, Boston, MA (CF); University of North Carolina Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, School of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, NC (FI).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155431PMC
August 2014

Progress against GI cancer during the American Society of Clinical Oncology's first 50 years.

J Clin Oncol 2014 May 21;32(15):1521-30. Epub 2014 Apr 21.

American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.4121DOI Listing
May 2014

International adaptations of NCCN Clinical Practice Guidelines in Oncology.

J Natl Compr Canc Netw 2014 May;12(5):643-8

From aNational Comprehensive Cancer Network, Fort Washington, Pennsylvania; bFox Chase Cancer Center, Philadelphia, Pennsylvania; cUCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; dRobert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; and eUniversity of Washington/Seattle Cancer Care Alliance, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0068DOI Listing
May 2014

Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicities.

J Clin Oncol 2014 Apr 10;32(10):991-6. Epub 2014 Feb 10.

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.5195DOI Listing
April 2014

American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes.

J Clin Oncol 2014 Apr 17;32(12):1277-80. Epub 2014 Mar 17.

Lee M. Ellis, University of Texas MD Anderson Cancer Center, Houston, TX; David S. Bernstein and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Emile E. Voest, University Medical Center Utrecht, Utrecht, the Netherlands; Jordan D. Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN; Daniel Sargent, Mayo Clinic, Rochester, MN; Patricia Cortazar, US Food and Drug Administration, Silver Spring, MD; Elizabeth Garrett-Mayer, Medical University of South Carolina, Charleston, SC; Roy S. Herbst and Rogerio C. Lilenbaum, Yale Cancer Center, New Haven, CT; Camelia Sima and Mithat Gonen, Memorial Sloan-Kettering Cancer Center, New York, NY; Alan P. Venook, Helen Diller Family Comprehensive Cancer Center at University of California San Francisco, San Francisco, CA; Neal J. Meropol, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH; Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Boston, MA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/03/14/JCO.2013.53
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.53.8009
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.53.8009DOI Listing
April 2014

Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance).

Clin Cancer Res 2013 Dec 4;19(24):6957-66. Epub 2013 Oct 4.

Authors' Affiliations: Division of Medical Oncology; Alliance Statistics and Data Center, Duke University Medical Center; Durham, North Carolina; Section of Hematology/Oncology, University of Chicago Cancer Research Center; Chicago, Illinois; Department of Surgery, Brigham and Women's Hospital & Harvard Medical School; Boston, Massachusetts; Department of Internal Medicine, Ohio State University; Columbus, Ohio; and Division of Medical Oncology, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-0926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219241PMC
December 2013

A review of hepatocellular carcinoma (HCC) staging systems.

Chin Clin Oncol 2013 Dec;2(4):33

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2013.07.05DOI Listing
December 2013

Biomarkers in colon cancer: the chasm between expectations and reality.

Oncology (Williston Park) 2013 Aug;27(8):758, 763

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
August 2013